Cynata Therapeutics LimitedASX: CYP

Target Market Determination

· Issued by Cynata Therapeutics Limited via ASX

Filed with ASX ·

Cynata Therapeutics Limited Level 3, 100 Cubitt Street, Cremorne VIC 3121 8 October 2026 Target Market Determination Made by: Cynata Therapeutics Limited ACN 104 037 372 (Issuer or Cynata) Product: Options to acquire fully paid ordinary shares (Shares) in the Issuer (Options) to be issued under...

View Attachment

6ix hasn’t read this filing yet.

Cynata Therapeutics Limited on 6ix

Earlier from Cynata Therapeutics

Later from Cynata Therapeutics

All Cynata Therapeutics news releases